Results 131 to 140 of about 31,480,937 (161)

Targeting HLA-E in Lung Cancer: The Therapeutic Potential of IRF5-Engineered M1-Macrophage-Derived Exosomes. [PDF]

Clin Respir J
Feng X, Lai X, Zhou M, Bie J, Li T, Wang D, Chen S, Hu X, Wang C, Xu P.   +9 more
europepmc   +1 more source

The Association of HLA-E Ligand and NKG2 Receptor Variation With Relapse and Mortality After Haploidentical Related Donor Transplantation. [PDF]

Transplant Cell Ther
Petersdorf EW, McKallor C, Malkki M, Hsu K, He M, Spellman SR, Gooley T, Stevenson P.   +7 more
europepmc   +1 more source

Senescent Tumoral HLA-E Reshapes Microenvironment through Impairing NK Cell-Dendritic Cell-T Cell Network in Malignant Pleural Effusion from Lung Cancer. [PDF]

Int J Biol Sci
Tsai YM, Hung JY, Wu YY, Tsai HP, Wu KL, Lee TH, Chiang HH, Chang WA, Lee HC, Pan SF, Chuang KC, Jian SF, Wu LY, Hsu YL.   +13 more
europepmc   +1 more source

Viral sequence determines HLA-E-restricted T cell recognition of hepatitis B surface antigen. [PDF]

Nat Commun
Murugesan G, Paterson RL, Kulkarni R, Ilkow V, Suckling RJ, Connolly MM, Karuppiah V, Pengelly R, Jadhav A, Donoso J, Heunis T, Bunjobpol W, Philips G, Ololade K, Kay D, Sarkar A, Barber C, Raj R, Perot C, Grant T, Treveil A, Walker A, Dembek M, Gibbs-Howe D, Hock M, Carreira RJ, Atkin KE, Dorrell L, Knox A, Leonard S, Salio M, Godinho LF.   +31 more
europepmc   +1 more source

Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies. [PDF]

Biomedicines
Ruiz-Lorente I, Gimeno L, López-Abad A, López Cubillana P, Fernández Aparicio T, Asensio Egea LJ, Moreno Avilés J, Doñate Iñiguez G, Guzmán Martínez-Valls PL, Server G, Ferri B, Campillo JA, Martínez-Sánchez MV, Minguela A.   +13 more
europepmc   +1 more source

CD8⁺ T cell targeting of tumor antigens presented by HLA-E. [PDF]

Sci Adv
Iyer RF, Verweij MC, Nair SS, Morrow D, Mansouri M, Chakravarty D, Beechwood T, Meyer C, Uebelhoer L, Lauron EJ, Selseth A, John N, Thin TH, Dzedzik S, Havenar-Daughton C, Axthelm MK, Douglas J, Korman A, Bhardwaj N, Tewari AK, Hansen S, Malouli D, Picker LJ, Früh K.   +23 more
europepmc   +1 more source

A monoclonal antibody that recognizes a unique 13-residue epitope in the cytoplasmic tail of HLA-E. [PDF]

Mol Immunol
Verhaar ER, Gan J, Buhl S, Li Z, Horowitz A, Ploegh HL.   +5 more
europepmc   +1 more source

All-Atom Simulations Reveal the Effect of Membrane Composition on the Signaling of the NKG2A/CD94/HLA-E Immune Receptor Complex. [PDF]

J Chem Inf Model
Ljubič M, Perdih A, Borišek J.
europepmc   +1 more source

Torque teno viruses exhaust and imprint the human immune system via the HLA-E/NKG2A axis. [PDF]

Front Immunol
Vietzen H, Simonitsch C, Friedel B, Berger SM, Kühner LM, Furlano PL, Florian DM, Görzer I, Koblischke M, Aberle JH, Puchhammer-Stöckl E.   +10 more
europepmc   +1 more source

Unlocking the therapeutic potential of the NKG2A-HLA-E immune checkpoint pathway in T cells and NK cells for cancer immunotherapy. [PDF]

J Immunother Cancer
Li Y, Li Z, Tang Y, Zhuang X, Feng W, Boor PPC, Buschow S, Sprengers D, Zhou G.   +8 more
europepmc   +1 more source